Sale by Third Rock Ventures V, L.P. / Third Rock Ventures GP V, LP / TRV GP V, LLC / Third Rock Ventures VI, L.P. / Third Rock Ventures GP VI, L.P. / TRV GP VI, LLC
271,495 shares · @ $40.12 · $10,892,651
Rapport Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $37.11
-7.1% in 7d after detection
Post-detection moves
1h
—
1d
-3.1%
3d
-1.2%
7d
-7.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS